Latest Kaiser Health News Stories
Even as it chips away at Obamacare, the Trump administration is solidly behind state-based initiatives to cover high-cost patients, known as “reinsurance” programs. It approved two more last month.
Many insurers added surcharges to policies they sold to individuals last year to make up for a cut in federal funding. Now, federal officials suggest that states encourage insurers to sell policies without those surcharges outside of the marketplace to help people who don’t get a premium subsidy.
With its expansion to Hawaii this year, medical aid-in-dying is now approved in eight U.S. jurisdictions. Even when legal, the controversial practice of choosing to die after a terminal diagnosis is difficult, said one Seattle man who shared his final deliberations.
Federal officials are proposing a rule to prohibit home health aides paid directly by Medicaid from having their dues for the powerful Service Employees International Union automatically deducted from their paychecks. The effort would likely mean those workers are far less likely to pay dues and could diminish the union’s influence.
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.
In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Anna Edney of Bloomberg News, Margot Sanger-Katz of The New York Times and Kimberly Leonard of the Washington Examiner talk about the latest Trump administration efforts to address high drug prices, what’s next for short-term health insurance plans and insider trading charges against a New York GOP congressman.
The devastating loss of a promising young doctor prompts soul-searching and action at one of the nation’s largest emergency room staffing companies.
Many of the GOP-led states seeking to overturn the Affordable Care Act could end up jeopardizing the health of their own residents, who suffer from preexisting conditions at rates higher than the national average. The ACA requires insurers to cover people with histories of illness and not charge them more for it. If the law is overturned, that protection could be lost, as California Healthline reporter Harriet Rowan explains on “The VICE Guide to Right Now” podcast.
States are passing laws that limit a doctor’s ability to prescribe opioids. Doctors and patients alike are wrestling with what that means in cases of chronic pain.
In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Anna Edney of Bloomberg News, Alice Ollstein of Talking Points Memo and Kimberly Leonard of the Washington Examiner talk about the new push on health legislation by Republicans in the House, as well as developments on Medicaid work requirements, drug prices and the fate of children separated from their parents at the U.S.-Mexican border. Plus, for extra credit, the panelists offer their favorite health stories of the week.
Dramatic policy swings, from an unprecedented expansion of transgender rights under the Obama administration to the unpredictable reduction of trans rights under President Donald Trump, have left many trans Americans feeling the whiplash.
After a San Francisco speech focused mostly on Medicare, Seema Verma fielded questions that underscored the administration’s differences with California on other key health care issues.
A coalition of Republican states has launched a legal challenge to the Affordable Care Act, including provisions requiring insurers to offer coverage to people with preexisting conditions without raising rates. An analysis shows that some of these states have the highest proportion of such residents.
Republicans’ overwhelming majorities in the state legislature make pursuing a policy that could benefit 660,000 uninsured adults a “long shot,” political analysts say.
Advocates of the sweeping health law view this move by the Trump administration as its most recent act of sabotage. But not everyone views it as a mortal blow.
Other readers ask what can be done to challenge unexpected medical bills — whether the result of an emergency room visit or after a change in prescription drug coverage.
A survey of 49 states reveals that an estimated 144,000 inmates with hepatitis C, a curable but potentially fatal disease, can’t get the expensive drugs they need to cure it.